Reata Pharmaceuticals, Inc(NASDAQ:RETA) 
Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs,...
Website: http://www.reatapharma.com
Founded: 2002
Full Time Employees: 220
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-29
P
O 88.81
H 91.37
L 87.73
C 90.04
V 521,121
10EMA 90.04
20EMA 90.04
60EMA 90.04
120EMA 90.04
250EMA 90.04